Upstream Processing Featured Articles

81. GlaxoSmithKline To Fully Acquire Cellzome For £61M 5/15/2012

    GlaxoSmithKline plc (GSK) recently announced that it has entered into an agreement to acquire those shares it does not currently own in Cellzome, a leader in the development and advancement of proteomics technologies, for £61 million (US$99M) in cash. Cellzome, a privately owned company with laboratories in Cambridge, UK, and Heidelberg, Germany, will become part of GSK’s R&D organisation.

82. GE Healthcare Life Sciences Launches Capto™ L Chromatography Medium For Capture Of Antibodies And Antibody Fragments 5/8/2012

    GE Healthcare’s Capto L affinity chromatography medium (resin) is designed for the purification of antibody fragments. It combines a rigid, high-flow agarose matrix with the immunoglobulin-binding recombinant protein L ligand, which has strong affinity for the variable region of antibody’s kappa light chain.

83. 3M Purification Inc. Introduces New Zeta Plus Encapsulated, Single-Use Depth Filtration Products 5/4/2012

    3M Purification Inc. has expanded its portfolio of Encapsulated Zeta Plus single-use depth filtration capsules.  The two new product lines – Zeta Plus Scale-up Capsule Filters and new single-layer media grades for Zeta Plus Encapsulated capsules – are designed with our industry leading Zeta Plus depth filter media, designed for applications in the bio-pharmaceutical industry including cell culture clarification, downstream process protection, virus, DNA and lipid reduction, and host cell protein (HCP), protein aggregate, endotoxin and anti-foaming agent removal.

84. Lpath Receives First U.S. Patent For Anti-LPA Antibody, Lpathomab 4/25/2012

    Lpath, Inc. (OTCBB: LPTN), the industry leader in lipidomics-based therapeutics, received official notification from the U.S. Patent and Trademark Office (USPTO) that it has been issued a key patent protecting Lpathomab™, a monoclonal antibody against lysophosphatidic acid (LPA).

85. HPLCs, Mass Specs, LC/GC Systems, And General Lab Equipment To Be Auctioned April 11 4/5/2012
    By Order of Global Biotech & Pharmaceutical Companies, Research Institutions and Clinical Research Organizations (CRO)
86. Peregrine Launches PS-Targeting Clinical Imaging Program 4/4/2012
    Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM), a clinical-stage biopharmaceutical company developing first-in-class monoclonal antibodies for the treatment and diagnosis of cancer and infectious diseases, today announced that it has launched a program for its experimental phosphatidylserine (PS)-targeting molecular imaging candidate, ¹²⁴I-PGN650, for the imaging of multiple solid tumor types.
87. Single Antibody Shrinks Variety Of Human Tumors Transplanted Into Mice, Study Shows 3/29/2012

    Human tumors transplanted into laboratory mice disappeared or shrank when scientists treated the animals with a single antibody, according to a new study from the Stanford University School of Medicine. By Krista Conger

88. New Compact, Research-Grade UV-VIS Spectrophotometers Deliver Industry's Highest Absorbance Level And Ultra-Low Stray Light 3/21/2012
    Shimadzu Scientific Instruments has launched the compact UV-2600 and UV-2700 UV-Vis spectrophotometers, which feature advanced optical systems and Shimadzu’s proprietary “Lo-Ray-Ligh” diffraction gratings.
89. GE Healthcare And BAC Collaborate To Launch New Bioprocess Affinity Resin 3/20/2012

    GE Healthcare, the healthcare business of GE and BAC BV, the leading provider of antibody-based affinity purification technology, announced recently that, following a successful collaboration between the two companies, GE Healthcare Life Sciences has added a new and innovative affinity resin to its portfolio of technologies for the purification of antibody-based fragments.

90. EMD Millipore Launches Mobius CellReady 50 L Single-Use Stirred Tank Bioreactor 3/20/2012
    EMD Millipore, the Life Science division of Merck KGaA of Germany, recently expanded the Mobius CellReady Bioreactor portfolio with the launch of a 50 L single-use stirred tank bioreactor for process development and pilot scale mammalian cell culture.